Investigator-Led Research to Improve the Diagnostic Assessment of Platelet Function Disorders: Reflections on the Challenges and Rewards

IF 2.2 4区 医学 Q3 HEMATOLOGY
International Journal of Laboratory Hematology Pub Date : 2026-07-12 Epub Date: 2026-04-13 DOI:10.1111/ijlh.70110
Catherine P. M. Hayward
{"title":"Investigator-Led Research to Improve the Diagnostic Assessment of Platelet Function Disorders: Reflections on the Challenges and Rewards","authors":"Catherine P. M. Hayward","doi":"10.1111/ijlh.70110","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Investigator-led research and quality improvement initiatives have led to important improvements in the diagnostic assessment of platelet function disorders (PFD).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Personal reflections were used to summarize our contributions to knowledge on PFD diagnostic assessment, pathogenesis, and bleeding risks.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Light transmittance platelet aggregometry (LTA) and whole mount electron microscopy assessment for platelet dense granule deficiency (DGD) both detect abnormalities that are highly predictive of a bleeding disorder. Observations on LTA findings that are predictive of a bleeding disorder (including those specific to certain conditions) have been incorporated into guidelines to reduce LTA interpretation errors. Efforts to improve LTA assessment of PFD with thrombocytopenia (e.g., Bernard Soulier syndrome) have led to validated, trustworthy diagnostic procedures. Commonly encountered PFD that manifest with abnormal aggregation responses to multiple agonists and/or DGD are now established to have significantly increased bleeding risks, emphasizing the need for diagnosis and treatment. Unraveling of the molecular pathogenesis of some specific PFD has provided important insights and simplified diagnosis. In the case of Quebec platelet disorder (QPD), the pathogenesis is a unique gain-of-function defect in fibrinolysis from a mutation that repositions a megakaryocyte-specific enhancer that normally upregulates <i>VCL</i> expression during megakaryopoiesis and “rewires” <i>PLAU</i>, increasing its expression &gt; 100-fold in megakaryocytes only. Presently, the molecular causes of many “commonly encountered” PFD await elucidation.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Research has meaningfully improved diagnostic laboratory testing for PFD. Unraveling the causes of “commonly encountered” PFD will be important to understanding their pathogenesis and increasing the yield of diagnosis by genetic investigations.</p>\n </section>\n </div>","PeriodicalId":14120,"journal":{"name":"International Journal of Laboratory Hematology","volume":"48 4","pages":"721-731"},"PeriodicalIF":2.2000,"publicationDate":"2026-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ijlh.70110","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Laboratory Hematology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ijlh.70110","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/13 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Investigator-led research and quality improvement initiatives have led to important improvements in the diagnostic assessment of platelet function disorders (PFD).

Methods

Personal reflections were used to summarize our contributions to knowledge on PFD diagnostic assessment, pathogenesis, and bleeding risks.

Results

Light transmittance platelet aggregometry (LTA) and whole mount electron microscopy assessment for platelet dense granule deficiency (DGD) both detect abnormalities that are highly predictive of a bleeding disorder. Observations on LTA findings that are predictive of a bleeding disorder (including those specific to certain conditions) have been incorporated into guidelines to reduce LTA interpretation errors. Efforts to improve LTA assessment of PFD with thrombocytopenia (e.g., Bernard Soulier syndrome) have led to validated, trustworthy diagnostic procedures. Commonly encountered PFD that manifest with abnormal aggregation responses to multiple agonists and/or DGD are now established to have significantly increased bleeding risks, emphasizing the need for diagnosis and treatment. Unraveling of the molecular pathogenesis of some specific PFD has provided important insights and simplified diagnosis. In the case of Quebec platelet disorder (QPD), the pathogenesis is a unique gain-of-function defect in fibrinolysis from a mutation that repositions a megakaryocyte-specific enhancer that normally upregulates VCL expression during megakaryopoiesis and “rewires” PLAU, increasing its expression > 100-fold in megakaryocytes only. Presently, the molecular causes of many “commonly encountered” PFD await elucidation.

Conclusions

Research has meaningfully improved diagnostic laboratory testing for PFD. Unraveling the causes of “commonly encountered” PFD will be important to understanding their pathogenesis and increasing the yield of diagnosis by genetic investigations.

Abstract Image

改善血小板功能障碍诊断评估的研究者主导研究:挑战与回报的思考
研究者主导的研究和质量改进倡议已经导致血小板功能障碍(PFD)诊断评估的重要改进。方法:通过个人反思,总结我们在PFD诊断评估、发病机制和出血风险方面的贡献。结果:透过率血小板聚集(LTA)和全贴片电镜评估血小板致密颗粒缺乏症(DGD)都能检测出高度预测出血性疾病的异常。预测出血性疾病的LTA结果(包括特定条件下的观察结果)已纳入指南,以减少LTA解释错误。努力提高LTA评估PFD伴血小板减少症(例如,Bernard Soulier综合征)已经导致验证,可靠的诊断程序。常见的PFD表现为对多种激动剂和/或DGD的异常聚集反应,目前已确定其出血风险显著增加,强调了诊断和治疗的必要性。揭示一些特定PFD的分子发病机制提供了重要的见解和简化了诊断。在魁北克血小板疾病(QPD)的病例中,其发病机制是纤维蛋白溶解中一种独特的功能获得性缺陷,这种缺陷是由巨核细胞特异性增强子的突变引起的,该增强子通常在巨核细胞形成过程中上调VCL的表达,并“重新连接”PLAU,仅在巨核细胞中将其表达增加100倍。目前,许多“常见的”PFD的分子原因有待阐明。结论:研究有意义地改善了PFD的诊断实验室检测。揭示“常见”PFD的病因对于了解其发病机制和提高遗传调查的诊断率非常重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.50
自引率
6.70%
发文量
211
审稿时长
6-12 weeks
期刊介绍: The International Journal of Laboratory Hematology provides a forum for the communication of new developments, research topics and the practice of laboratory haematology. The journal publishes invited reviews, full length original articles, and correspondence. The International Journal of Laboratory Hematology is the official journal of the International Society for Laboratory Hematology, which addresses the following sub-disciplines: cellular analysis, flow cytometry, haemostasis and thrombosis, molecular diagnostics, haematology informatics, haemoglobinopathies, point of care testing, standards and guidelines. The journal was launched in 2006 as the successor to Clinical and Laboratory Hematology, which was first published in 1979. An active and positive editorial policy ensures that work of a high scientific standard is reported, in order to bridge the gap between practical and academic aspects of laboratory haematology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书